Looking for an ePrescribing solution with EPCS?DxScript is intuitive, easy-to-use and DEA compliant in ALL 50 states. More info
We design cutting edge software solutions for the modern day medical practice.Our innovative solutions lend themselves to the provider's workflow, resulting in delivery of better patient outcomes. About Us
Don’t just take our word for it…read what our partners have to say.
“DxWeb has been a valued partner throughout the integration of DxScript and McKesson Practice Choice™. The prescribing world is heavily governed by outside factions such as agencies, aggregators and pharmacies, but DxWeb does a great job of complying with each of these while still being open to our users’ workflow needs. From the initial requirements, through development and then go-live, they have been knowledgeable, flexible and most of all, responsive. Whatever we may ask, they help us find a way to make it work or propose an alternative, often better, solution. That hasn’t ended with go-live; as we continue to sign providers and work through projects like EPCS and mobile applications, they are just as quick to respond as on Day 1 of the partnership”
“DxWeb was integral in assisting our NY customers meet the EPCS deadline in 2016. The product provided a simple, easy to use solution to a very challenging obstacle. The responsiveness of the staff made the development and roll-out significantly easier than we had imagined.”
“In 2018 Premise Health, the leading provider of direct healthcare, partnered with DxWeb as a solutions provider of standalone electronic prescribing of controlled substances (EPCS). The decision to partner with DxWeb was a result of its ability to truly listen to organizational needs, define best practices, and develop appropriate solutions. Premise presented a unique set of needs and challenges and the team at DxWeb helped to solve for them. They provided direct communication and superior customer service. DxWeb has proven to be a valued partner, so much so that Premise is now recommending them to others. (2019)”